In a recent article, Li et al. found that miR-145 plays a key role in the pathogenesis of AD; They discovered that miR-145 is downregulated in TAAD and that overexpression of miR-145, through targeting connective tissue growth factor (CTGF), enhances the progression of TAAD (Figure 1). This evidence concerns the gene CCN2 and Alzheimer disease.